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I.

C.HEMISTRY
Two amino acids are known to contain sulphur, cystine and
methionine.

Cystine is a naturally occurring amino acid ob-

tained in large quantities from material containing keratin
suoh as hair, feathers, etc.
Methionine was first isolated by Barger, and several other
chemists have since synthesized it.

It is an essential amino

acid whereas cystine is not.

"
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A reduced form of oystine is cysteine which is an amino acid
of importance in biological oxidations.
Homocystine is the next higher homolog of cystine which Du
Vigneaud has obtained by heating methionine with sulphuric acid.
Djenkolic acid, the cysteine thioacetal of formaldehyde, has
been isolated from the djenkol bean, Pithecolobium lobatum.
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Lanthionine is a product of the acid hydrolysis of wool.
Methionine and oystine are the only two of the above amino
acids which have been reported in the literature as to their use
in treating liver disorders so this thesis will deal with them
only {O).
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TOXIC HEPATITIS
L. L. Miller, PHD, and G. H. Whipple, M.D., from the Department of Pathology of the University of Rochester School
of Medicine and Dentistry, Rochester, New York, may be considered as the fathers of the work on the role of cystine and
methionine in treating liver disorders.

The stimulus for

their investigations was the pre-existing knowledge that liver
damage due to certain chemical intoxications could be augmented by decreasing the plasma protein level and conversely
could be minimized or presented by maintaining a.high plasma
protein level.
In 1939, Goldschmidt, Vars, and Ravdin (2) experimenting
with the effect of chloroform anesthesia on rats noted that a
high protein diet, previous to the anesthesia would markedly
reduce the incidence of hepatic cellular necrosis.
Messinger and Halric:ins (3), in 1940, experimenting with
arsphenamine intoxication in dogs, added supportive evidence
to the growing contention that plasma proteins played a role
in protecting the liver against chemical injury.

The experi•

mental animals were given arsphenamine indoses of 0.03 gms.
per kg. or higher, and liver injury resulted to a greater or
lesser degree depending upon the diet fed.

A high protein

diet was found to be most effective in protecting the dogs

-,-

from the arsphenamine liver injury.

A high carbohydrate diet

was also found to be beneficial but was not as uniformly protective as the high protein diet and when liver injury did oc•
cur it was more marked than with the latter diet.

High fat

diets proved to be deleterious, as the arsphenemine treated
dogs showed marked progressive jaundice, severe liver injury
(as evidenced by liver function tests), and many became in•
toxicated to the point of death.
The above experimental work was the incentive for the work
of Miller and Whipple.
tein depleted dog,

In 1940

(4), they found that in a pro-

15 to 20 minutes of chloroform anesthesia was

frequently fatal with extensive hyaline liver necrosis sid the
typical picture of chloroform poisoning.

This amount of chloro-

form anesthesia was not found to be fatal if the dogs were not
previously depleted of their plasma proteins.

Thus they con-

firmed the findings of Goldschmidt, Vars, and Ravdin (J ), in

1939. In July of 1942, Miller and Whipple (f ) published the
results of their experiments which were to pave the way for all
further investigations into the role of the sulphur containing
amino acids in treating liver disorders.

Most of their work,

however, was done in 1941, the year before their publication.
This work began with the chemical analysis of livers of proteins
depleted dogs for nitrogen and sulphur content.

They found that

these autopsied livers showed nitrogen sulphur ratios of
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14

or

15 to l whereas that of normal pups and adult dogs was 11 or
12 to 1.
This meant, presumably, that in the former there was a
smaller amount of available sulphur - containing amino acids.
It was also obvious that during long protein depletion on a
very low protein diet, the liver was drained of its sulphur
a little more completely than of its nitrogen.

Working from

this groundwork of knowledge, Miller and Whipple assumed that
the lowering of the sulphur content of the liver might bear
some significant relationship to the susceptibility of such a
liver to the toxic action of chloroform.

The logical pro-

cedure would then be to replenish this liver with sulphur.
This they proceeded to do using various types of sulphur containing and non-sulphur containing amino acids.

The variety

of non-sulphur containing amino acids were found to be entirely lacking in any protective action;

but much to the joy

of the experimenters, methionine was found to give considerable
protection against the liver injury even when given three to
four hours after the chloroform anesthesia.

This discovery was

to arouse considerable interest in the scientific mind and
initiated the sulphur containing amino and methionine into the
experimental world of liver disease therapy.

Miller and Whipple

could give no adequate explanation for the liver cell necrosis
due to chloroform intoxication.

However, they speculated that
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the sulfhydry'l groups of vital enzyme systems must be con•
cerned.

The protein depleted liver contained an insufficient

amount of sulphur to form the sulfhydrYl groups for these
enzymes.

When methionine was fed to these dogs it appeared

in great amounts in the liver.

They believed that the methio•

nine was incorporated into the liver protein matrix just aa
readily as the same protein matrix was depleted of its sulphur
by prolonged low protein diet, thereby replenishing the supply
of sulphur for the all important enzyme systems.
Off additional interest was the observation that methionine given 3 to

4

hours after chloroform anesthesia gave com-

plete protection but when given
gave no protection.

4 to

6 hours after anesthesia it

This proved that the disturbance of the

enzyme systems was reversible during the first 3 to
anesthesia hours, but after

4 to

4

post

6 hours had elapsed the liver

cells were dead and could not take up the sulphur and consequently the process was irreversible.
In the same year, 1942, that Miller and Whipple published
their work, Dr. Paul Gyorgy (5), of the Babies and Childrens'
Hospital and the Department of Pediatrics, School of Medicine,
Western Reserve University, Cleveland, Ohio, studied the effect
of dietary factors in the production of hepatic injury in rats.
He found that hepatic injury could be produced by feeding rats

-s-

a relatively high protein diet if other factors were withheld.
This seemed to prove that the low protein diets per se were
not the cause of the hepatic injury.

Instead, he found that

the correlation was between the absolute and relative supply
of methionine and cystine as components of food proteins, as
well as the presence of choline •in the diet.

With the use of

a protein which was particularly rich in methionine, he found
that even-4:ft a low intake might prevent hepatic injury whereas
a ration containing a high percentage of protein which, in relation to methionine, was relatively and absolutely rich in
cystine;
injury.

was definitely conducive to the production of hepatic
He found that either methionine alone or cystine plus

choline when added to a starvation diet would protect the rats
from liver damage.

Cystine al on~. only aggravated the condition

but when it was administered with choline it seemed to act just
as methionine alone did in protecting the liver.

He thus as-

sumed that :methionine was formed in the body by the inter-reaction of cystine plus choline.

Gyorgy's work was the first of

its kind since that of Miller and Whipple in 1941.

It added

additional weight to the findings of the latter two workers and
showed that methionine definitely had a protective action on the
liver.

It also indicated that cystine plus choline wauld give the

same beneficial results as methionine alone.

However, the suc-

ceeding reports in the literature concerning the treatment of
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various chemical intoxications make no mention of cystine plus
choline therapy.

Instead methionine was used exclusively for

these experiments.
In 19l.i4, Drs. Goodell, Hanson, and Ha'llkins (6) from the
Department of Pathology, University of Rochester School of
Medicine, conducted experiments on dogs whose plasma protein
levels were lowered and whom were subsequently given massive
doses of :map,ar-sen.

The dogs were divided into three groups.

The first group was not protected from methionine;
was protected with methionine;

the second

and the t hird consisted of

animals that were alternately protected and unprotected.

Their

plasma protein levels were depleted by fasting for one week and
then being placed on a low -protein diet.

After their plasma

protein levels were low enough to indicate that their protein
stores were depleted, mapharsen in distil l ed water solution
was given intravenously in varying doses.
used, it was either given by mouth

24

When methionine was

hours prior to the ad•

~~nistration of mapharsen, or it was given intravenously immediately before the administration of' mapharsen.

Comparative-

studies of the icterio indieies of the three groups showed
clearly that methionine did protect the dogs from severe liver
damage.
In 191.i4, Drs. Beattie, Wechtel, Herbert, and Steele

,

~-

(7),

from the U.

s.

Military Hospital, E.T.

o.,

and the Bernhard

Baron Research Laboratories, Royal College of Surgeons of England, had the opportunity of studying a case of carbon tetrachloride poisoning in a human subject.
An

A:rmy Air Force Sergeant-pilot, aged 23, ingested by

mistake, two lar~ swallows of carbon tetrachloride at 4:15 P.M.
on October 2, 1943.

The quantity was determined later to be

between 30 and l.i.O ml.
at 7tl7 A.M.

No food had been taken since breakfast

At llsOO A.M., on October 3, 1943, he came under the

observation of the afore named doctors.
2 gm. of d-1 methionine by mouth.

At 12:30 P.M. he was given

At 3:30 P.M., l ml of casein

digest methionine solution was injected slowly into an antecubital
vein.

Five minutes later 5 ml. more was injected, both without

reactions.

Continuous infusion of the solution by a Murphy

drip apparatus was begun immediately at the rate of 2 ml. per
minute, and contimued until 436 ml. had been infused.

At 9:oo ·

A.M. on October 5th, he was given two more doses of methionine
by mouth, consisting of 2 gms. each.

During the period of ob-

servation his food was weighed and its nitrogen and sulphur
content estimated.
were also measured.

The urinary output of nitrogen and sulphur
An

attempt was made to follow the mode of

action of methionine by estimating the nitrogen and sulphur
balance of the patient and by determining the partition of the
urinary sulphur between the oxidized (total sulphate) and the
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unoxidized {neutral) fractions.

It would appear from the bal-

ance figures that there was a nitrogen retention of 6 gms. over
the whole period.
loss in the feces.

This may well be accounted for by nitrogen
It should be noted, however, that on the 3rd

and 4th days, there was a total negative balance of 7 gms. which
was

almost eliminated by the sum of the positive balances of the

5th and 6th days.

While it is difficult to believe that the ne-

gative balance represents the rapid destruction of cellular elements followed by an equally rapid replacement, it may well be
that on the 3rd and 4th days, the hepatic metabolic processes
were impaired, but returned to normal on the 5th and 6th days
and continued so during the rest of the period.
The positive sulphur balance was, however, proportionately
muoh greater.
That the liver damage was in the nature of a metabolic de•
rangement rather than an actual destruction of liver substance
is indicated by the partition of urinary sulphur.
by

{7)

Medas (cited

) has shown that of 3.2 gm. of d-1 methionine given

orally to a normal person, 95% is oxidized to sulphate and ex•
creted in the urine within

24

hours, causing no appreciable rise

in the unoxidized sulphur fraction.

As it has also been shown

by Martin and Thompson {cited by 7) that amino acids injected
at the rate of 10 gms. ~r hour do not spill over into the urine,
it is safe to assume that a normal person receiving the same
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treatment as this patient would have excreted in the urine the
major portion of the methionine sulphur as oxi4ized (total sulphate) sulphur within

24

hours.

This pat ient, however, excreted

an excessive amount of unoxidized sulphur during the first two
days, a quantity which was roughly equivalent to

65% of the

a-

mount of sulphur given therapeutically as methionine.
These considerations indicate that in carbon tetrachloride
poisoning, there is an abnormal metabolism of methionine and related compounds;

and it was assumed that in this pet ient it was

specifically the administration of methionine which prevented
further liver damage.
Dr. James H. Eddy, Jr., {8) from the Medical Department of
the Louisiana Ordnance Plant, conducted a study of
acute toxic hepatitis treated with methionine.
in July 1944.

His work began

Most of the cases were caused by trinitrotoluene

and at least 10 of them were seriously ill.
ities.

30 cases of

There were no fatal-

This is of interest in view of the published mortality

in T.N.T. hepatitis of

30 to 35%• It is also noteworthy that of

2 of his cases of T.N.T. hepatitis seen prior to using methio•
nine, l patient died and the second had a prolonged illness.

A-

mong the cases of toxic hepatitis treated l'lith methionine, the
length of hospitalization varied from
average of

4 days to 7 weeks with an

13 days. Treatment consisted of bed rest, a diet rich

with protein and carbohydrate and poor in fat, administration of
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multiple vitamin products plus added vitamin B complex and the
oral administration of methionine in doses of from 3 to 8 gms.
daily;

the average dose was 3 to

4

gms.

per day, but in two of

these cases the patients showed more jaundice and the dosage was
increased to 8 gms. daily and the patients fed by duodenal tube.
In both of these cases improvement was marked af'ter

48

hours.

This marked improvement led Dr. Eddy to believe that his regular
dosage of methionine was inadequate and that 6 to 8 gms. daily
for seriously ill patients should be considered.
Several cases of acute carbon tetrachloride hepatitis were
also treated with methionine by Dr. Eddy.

His results were sim-

ilar to those of Beattie, Wechtel, Herbert, and Steele
In

1945, F. s.

Daft and co-workers

(7).

(9) experimented with

rats

subjected to repeated inhalations of l, 2 dichlorethane {ethylene
dichloride).

They found that weanling rats maintained on low cho-

line diets were more susceptible to ethylene dichloride poisoning
than control animals.

When the low choline diets were supple-

mented with methionine antl choline the mortality af'ter exposure
was greatly reduced.
same effect.
tein

Increasing the casein content also had the

Weanling rats maintained al .d iets deficient in pro-

(6%) resisted the effects of the poisoning as well as the

control rats when adequate provision was made for methionine and
choline.

In this case it is evident that the choline and methio-

nine did protect the rats from the effects of the ethylene di-
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chloride and the assumption is made that they did so by preventing liver damage.

One does not know, from this experiment,

whether to give the credit to the methionine or choline or both.
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III
INFECTIOUS HEPATITIS

III

INFECTIOUS HEPATITIS
Two of the 30 cases of toxic hepatitis reported by Dr. Eddy
{8) in 1945, were diagnosed as epidemic hepatitis.

It is assumed

that these two patients were suffering from infectious hepatitis.
They were given methionine and improvement was striking in

4B hours.

In one of these patients, the jaundice returned when treatment
with methionine was stopped, but responded quickly when it was
given again.
Other observers did not confirm Dr. Eddy's promising results.
Perhaps it was because Dr. Eddy's two patients did not actually
have true infectious hepatitis.
and Witts (10), in
fectious hepatitis.

Higgins, O'Brien, Peters, Stewart,

1945, studied 37 patients suffering from inEvery alternate patient

was

given methionine.

It was estimated that the methionine content of the diet consumed
daily was about

2.5 gms.

Twice this amount was given to the treated

patients in addition to the

2.5 gm. consumed in their diets. This

meant that the control group received about
the treated group received about

2.5 gms. per day and

7.5 gms. methionine per day.

A detailed biochemical study was made on al 1 the patients.
The conclusion arrived at was that treatment with methionine did
not significantly affect the clinical course of the illness, the
anorexia, or the average duration of biliuria or bilirubinemia.

-14-
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Wilson, Pollack, and Harris {11), in 1945, conducted studies
on a series of 100 service men suffering from infectious hepatitis.
D-1 methionine was given in datly doses of 5 gms. from the time of
admission until the urine was bile free.

This quantity of methio-

nine they estimated to be roughly equal to the average content of
the normal diet.

Comparison of the treated and control groups

was based on clinical and biochemical criteria.
criteria were (1)

The clinical

Duration of anorexia after admission, {2) dura-

tion of jaundice after admission (3)
ment after admission,

duration of liver enlarge-

(4) duration of liver tenderness after ad-

mission, (5) length of period in hospital, and frequency of relapses and recrudescences.
The biochemical criteria employed were (1) duration of biliuria, (2) interval between admission and return of serum bilirubin to 2 mg. per 100 ccs, (3) maximum serum bilirubin, and

(4)

hippuric acid synthesis after the disappearence of bile from the
urine.
The majority of the criteria showed a slight bias in favor
of the methionine-treated group, but the differences were not
statistically significant.

The hippuric acid test showed, if

anything, results slightly more favorable to the control group.
The disappointing results reported above seem to indicate
that methionine is of no value in treating infectious hepatitis.
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MALAR1AL HEPATITIS

IV

MALARIAL HEPATITIS
Cook and Hoffbauer (12). in ls46, used methionine in an attempt to protect the livers of 12 patients suffering from therapeutic malaria.

The patients were studied before, during, and

after the course of the disease in regard t o liver functions.
Four laboratory tests;

the cephalin - cholesterol flocculation,

the quantitative serum bilirubin, the quantitative Ehrlich reaction, and the bromsulfalein tests were used.
Alternate patients, six of the twelve, were given 8.1 gms.
'

of methionine orally per day in addition to a general hospital
diet.

The other six served as controls and received the same

diet without extra methionine.

The daily addition of the methio-

nine to the diet failed to provide any evidence;by the laboratory
tests,

1-

~

~

-
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V

FATTY LIVERS

V

FATTY LIVERS
It has long been resognized that fatty infiltration of the
liver may occur as the result of many varied circumstances.

Ac-

cumulation of fat in the liver is one of the most delicate indicators of interference with the health of the organ.

It is

marked in diabetes, pernicious anemia, chronic alcoholism, etc.
Starvation induces the condition, thus explaining in part the
frequency with which it is found in hospital autopsy lllaterial {13)•
The large globules of fat displace the nucleus to one side
of the cell, giving a signet-ring appearance.

It is evident that

there is no room for glycogen storage, and the blood sugar in
these oases is likely to be low {13).
In this thesis we are interested in the effect the sulphur
containing amino acids, cystine end :methionine, may have upon this
fatty infiltration of the liver from whatever the cause may be.
In 1940, Channon, Manifold, and Platt, (14) made an attempt
to understand the action of sulphur containing amino acids and
proteins on liver fat deposition.

They used rats for their ex-

periments and found that methionine exerted a preventive action
on fat deposition in the liver.
was found to be only

However, at its best, methionine

1/5 as intense as choline in its lipotropic
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action.

Greatly increased fat deposition was reported -with cystine

and diets low in caseinogen.

These findings brought up the question

as to whether the action of proteins on liver fat deposition was

not solely a function of their methionine content.
In that same year, Lester R. Dragstedt (15) demonstrated the
presence of an internal secretion of the pancreas which counteracted the fatty infiltration 0£ livers of diabetic dogs.
this unidentified hormone ftLipocaic".

He called

Extracts of pancreatic tis-

sue containing lipocaic proved to be satisfactory in relieving the
characteristic low concentration of blood lipids, impaired liver
function, decreased dextrose excretion, and insulin sensitivity
which eventually occurs in diabetic dogs even though they are on
adequate insulin therapy.

The above condi tion has also been com-

plained of again and again by Dr. Joslin (cited by (15) concerning
his human diabetic patients.

Dr. Dragstedt found thex these dia-

betic dogs on adequate insulin therapy showed marked fatty infiltration of the hepatic cells at autopsy.

Lipocaic administration

however, prevented this infiltration or reversed the already present process so that dogs receiving adequate insulin plus lipocaic
therapy showed normal livers at autopsy.
I)r.

David H. Rosenberg (16) observed the clinical counterpart

of Dr. Dragstedt's experimental work in one of his diabetic patients
treated with lipocaic.

-18-

The question that now arises is whether this unidentified
lipotropic substance in the pancrease, called

9

lipocaic" by

Dragstedt, is nothing more than methionine or even choline.

In

1945, Clark, Eilert, and Dragstedt (17) studied the effects of
lipocaic, me~hionine, and cystine on dietary fatty livers in the
white rat.

They found that fatty livers were produced in the

rats by diets rich in fat and low in protein and that these

fatty livers could be prevented by the addition of
methionine or 1.25 to
diets.

0.5

per cent

5.0 per cent pancreatic extract to the

The addition of

0.5 per cent cystine to the diet pro-

duced no significant effect on liver fat.

(This latter find-

ing differs somewhat from that of Channon, Manifold, and Platt

(14), who found cystine actually to augment the fatty infiltration).

Since there was no choline and less than 2 per cent

methionine in the pancreatic extract it was concluded that the
lipotropic effect of lipooaic on dietary fatty livers in rats
was due to some constituent other than choline, methionine, or
the non-specific action of proteins.
Chsi.koff, Entenman, and Montgomery (18), in

1945, explained

the action of lipocaic by suggesting that it was a proteolytic
enzyme which makes available for lipotropic purposes the bound
methionine contained in dietary protein.

This is a highly theor-

etical assumption and no proof of its value was offered.

-19-

c.

R. Treadwell (19), in

previous observers

1945, confirmed the reports of

(14, 17, 18), that methionine or choline

acted as lipotropic substances on the liver.

The reader is pro-

bably concerned with the frequent mention of choline in this
thesis since it is not a sulphur containing amino acid.

However,

it does seem to play a significant role in liver pathology along
with methionine and cystine.

Du

Vigneaud, Chaudler, Mayer and

Keppel (20), in 1939, demonstrated that the administration of
choline enabled the rat to utilize homocystine for growth purposes
in lieu of methionine.

It was suggested by this group that choline

makes possible the ·m viua methylation of homooysteine to methionine.
Du

Vigneaud, Chandler, Cohn and Brown (21), in 1940, in in-

genious experiments ml'hich deuterium was used as an identifying
element revealed that the methyl group of methionine could be
used by the rat for the s:,nthesis of choline.

The question of

the relationship of methionine to other methylations in the body
was undecided.

They suggested, however, that the presenae of

methyl groups in a utilizable form such as in methionine or choline
was essential in the diet.

This seemed to indicate that choline

was the ultimate therapeutic agent and that methionine was im-

portant only because of its donor methyl group used for the in
vivo synthesis of choline.

It had long been known that a methyl

group could be transferred from choline to homocysteine in the
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body and methionine be produced (20).

In 1941, Du Vigneaud {22)

proposed the converse hypothesis that methionine is the precursor
of choline in that it affords methyl groups for the synthesis of
choline in the body.

This hypothesis was published in view of

his work the preceding year, 1940 {21).
possibilities presented:

Thus we have the t1VO

either choline is the important com-

pound and is synthesized by acquiring a methyl group from methionine or methionine is the important compound as is synthesized
by acquiring a methyl group from choline.
CHL

CHOLINE

-----·'

METHIONINE

An editorial in the Journal of the .American Medical Associ-

ation (23), in 1942, on the significance of the labile methyl
group points out that studies of the chemical make up of lipotropic substances reveals that they all possess one chemical
group in common, namely, the methyl group.

This does not clarify

the problem of the relative importance of choline or methionine in
combatting fatty livers.

It may even be that the labile methyl

group itself is the actual lipotropic substance.

The one point

to remember is that methionine and choline do satisfactorily act
as lipotropic substances to the livers of rata and dogs and that
this fact alone could prove to be of great clinical significance.
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IA

VI
CIRRHOSIS OF THE LIVER
Cirrhosis, originally meaning a color, has come to connote
diffuse fibrosis of the liver affecting all lobes in about equal
degrees.

Because of condensation of the fibrous tissue with re-

sultant shrinkage and because of regeneration or over regeneration
of liver cells, the liver may become nodular or

8

hobnailed"

(24).

We will discuss cirrhosis in this broader aspect using the pathological classification offered by Charles L. Connor

(24).

We have seen that methionine has been very efficaciously used
in treating cases of toxic hepatitis in human patients and in preventing or reversing the process of fatty infiltration in the livers
of experimental dogs and rats.
It therefore seems logical to investigate the role that the
sulphur containing amino acids may play in treating or preventing
cirrhosis of the liver.

-22-

A
TOXIC CIRRHOSIS
According to Connor's classification (21.i.), there is one
type of liver cirrhosis called "toxic cirrhosis".

When this

condition is severe it is called nAcute Yellow Atrophy". There
is necrosis of hepatic cells due to chemical intoxication and the
loss of tissue is made up by fibroblastic proliferation of the
pre-existing connective tissue framework.

This type is obviously

the advanced stage of the condition due to chemical intoxications
which was discussed fully under "Toxic Hepatitis".

It was shown

in that section that methionine or cystine pl tts choline was of definite value in treating such acute conditions and it is logical
to assume that such treatment would prevent the appearance of the
far advanced cirrhotic stage.

B
FATTY CIRRHOSIS
Connor (24) also includes in his classification a type of
cirrhosis which he calls ttFatty Cirrhosis".

This condition always

follows fatty infiltration of the liver which causes pressure atrophy of the liver cells at the periphery of the lobules with resultant fibroblastic proliferation.

It is most commonly associated

with long-continued alcoholism or diabetes mellitus in which there
has been a preceding fatty infiltration of the liver. It is also
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rarely seen in hypothyroidism or lesions of the pituitary or midbrain as in progressive lenticular degeneration {Wilson's Disease).
In all of these instances, there has been an alteration in lipid
or carbohydrate metabolism or both

(25).

Here again it is easy to associate the experiments reported in
the section of "Fatty Livers" with this condition called "Fatty
Cirrhosis".

The latter condition is always preceded by a i;ro-

longed period of time during which the liver has an abnormally
high fat content.

Methionine has proved successfully in mobilizing

the fat from the fatty livers of experi111Bntal rats and dogs so it
is logical to belisve that it should do so in human subjeots and
if administered in time 110uld prevent the occurrence of fatty
cirrhosis.
The reader may wonder how he can distinguish a case of fatty
cirrhosis due to alcoholism from a true case of alcoholic portal
cirrhosis.

The answer is that the dividing line is indefinite

indeed and that the differentiation is I1Bde mostly for clarity in
this thesis.

However, Ralli, Rubin, am Rinzler, (26), in studying

25 normal subjects, 25 alcoholic patients, and 5 patients with no
history of alcoholism, but with cirrhosis of the liver, concluded
that cirrhosis could occur ~ithout being preceded by a period of
fatty infiltration.

It is this latter type of cirrhosis which will

be discussed under the section, "Portal Cirrhosis".

In this section

we are interested only in those cases of cirrhosis which were pre-
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ceded by a definite period of fatty infiltration of the liver.
In

1943,

Fagin et al

(27)

decided to determine whether the

beneficial effects of amino acid administration to their 5 patients
with fatty cirrhosis was due to the lipotropic action of the amino
acids or not.

They attempted to accomplish this by running chem-

ical determinations of the lipid and nitrogen content of the autopsied livers of patients dying with fatty cirrhosis.

It was found

that specimens· from patients who had received amino acids as part
of their therapy contained a greater percentage of protein and a
lesser percentage of fat than specimens from patients who had not
received amino acids.

It was postulated that these results in-

dicated a lipotropio activity of the amino a.oid mixture, probably
due primarily to their methionine content, and that accordingly
the beneficial results seen in their living patients treated
with amino acids w9.s due to this li,potropic activity.

c

-

PORTAL CIRRHOSIS
According to Connor's (24) classification, all types of
liver cirrhosis other than the fatty or the toxic varieties,
should be called "Portal Cirrhosis•.

He abandons the terms

Laennees and Atrophic Cirrhosis to avoid confusion.

Biliary

cirrhosis is considered a type of portal cirrhosis which is
always asso~iated with biliary obstruction with or without in-
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fection.

Pigment cirrhosis is another type of portal cirrhosis

which is caused by irritating pigments or metals collecting at the
periphery of the lobules and causing a fibroblastic proliferation.
This may occur with numerous blood transfusions, copper intoxication,
pernicious anemia, hemochromatosis, etc.

Chronic alcoholism, however,

is the most common cause of portal cirrhosis (28).
Little work has been done on the actual treatment of portal
cirrhosis 'With sulphur containing amino acids even to thepresent
date, but there is sufficient evidence in related works to substantiate the efficacy of such treatment.

For example, it has been

long known that the serum albumin level is low in portal cirrhosis.
Grenet and Gilbert {29), 1907, were the first to report this finding and since that date this fact has been comm.on knowledge.

This

is not true, however, of the total serum protein, level which is
frequently elevated (30, 31).

The explanation offered for this is

that the portal vascular bed is ~istended and there is an increase
in collaterol portal circulation which allows for more absorption
of amino acids from the bowel

(30).

It then seemed that the logical way to treat these cirrhotic
patients was to elevate their serum albumen levels.
therapy, however, had its shortcomings.
studied the serum proteins of

36

suffering from portal cirrhosis.

This form of

Stacey (31), in 1945,

natives of Baghdad, Iraq, who were
He found a fall in albumen, rise

in globulin, and a reversal of the A/G ratio to be apparent in all
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of them.

The diet in this section of the country in which cir-

rrhosis of the liver is most common is deficient in protein, and
patients with cirrhosis are averse to taking food containing much
protein.

Since animals on a low protein diet develop low serum

albumen values, Stacey thought that the low serum albumen observed
was dietetic in origin.

However,

4 of his patients with cirrhosis

kept for 2 weeks on a high protein diet, showed no rise in serum
- albumen.

This led him to believe that in patients with cirrhosis

the body fails to produce albumen and the deficit is made up by increased englobulin production.

Since the synthesis of albumen from

engested amino acids is a function of the liver it is assumed that
liver cells in portal cirrhosis are in some way damaged so that they
can no longer carry out their normal functions.

It has been seen

how liver cells damaged by chemical intoxicants heve been restored
to norm.al function by methionine or cystine plus choline so it does
not seem absurd to anticipate beneficial results from this type of
therapy in portal cirrhosis.
Clinicians were slow to accept or even experiment with this
type of therapy in treating their cirrhotic patients.
Patek, in
in

1937 (32), reported 13 cases

Arthur J.

cif alcoholic cirrhosis and

1941 (33), reported 54 more cases of the same disease and in

neither report did he mention anything about the use of methionine,
cystine, or choline.

Instead, his type of treatment seemed to

consist of a nutritious diet and supplements rich in Vitamin B
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complex.

This could also be said of many other experimenters and

clinicians (.34).
In 1941, Daft, Sebrell, and Lillie (35) came to the rescue
of the cause.

They produced alcoholic cirrhosis in rats by feed-

ing them deficiency diets and substituting 20% alcohol for their
drinking water.

All of these rats died between the 46th and 111th

experimental days and all showed marked liver cirrhosis on gross
and histological examination.

In a preventative experiment, 40

litter mates were given 20 mg. of c_h oline daily or 0.7 methionine
in the diet, or the dietary casein was raised from 4% to
the expense of cornstarch.

3o%

at

None of these rats sacrificed at the

end of 90 to 140 experimental days, or dying during the experiment
showed any evidence of liver cirrhosis.

Casein is known to con-

tain a very high percentage of methionine so this experiment
shows that methionine or choline is of value in preventing liver
cirrhosis in rats.
Inl942, Brown and Muether {36) treated patients with hepatic
cirrhosis with l gm. of choline chloride per day and with diets
low in animal fats and cholesterol.

The caloric requirements

were balanced am vitamins A and F were supplied.

The protein

was largely supplied by skimmed milk since casein has a high
methionine content.

Marked improvement was noted clinically and

by laboratory test.

They also treated some of the patients with

the diet alone and claimed to get better results when choline
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chloride was supplemented.

Since choline seems to be identical

to methionine in its action in oases of toxic hepatitis, and in
its lipotropic properties, we may assume that good results in
treating portal cirrhosis with one could be attained with the
other also.
In

.t.

1942, Fagin and Zinn (37) reported the use of parenterally

administered amino acids in treating their patients with cirrhosis
of the liver.

Five patients with the clinical diagnosis of cir•

rhosis of the liver were selected at random fromthe wards.

Be-

cause of the possibility that patients with cirrhosis of the
liver might conceivably exhibit disorders of digestion clinically
unrecognized, the amino acids were administered intravenously in
order to make certain that they actually reaohed the liver.

The

mixture was prepared from a casein hydrolysate to which tryptophane was added.

The solution was ad~inistered daily af'ter the

pitients' breakfasts, for four weeks.

At the end of the month,

one patient exhibited great general improvement, three exhibited
moderate general improvement, and one remained unchanged • . These
results are not striking and what benefits were derived from the
treatment cannot be specifically attributed to the sulphur containing amino acids in the mixture.
In

1945, Drs. Pollard, Eckatein, and Ransom (38), of

Ann

Arbor, Michigan, reported on a case of xanthomatous biliary cirrhosis treated with choline and Inositol.
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They concluded that

the therapy did not seem to alter the oirrhotio oondition.
An inoidental finding by Viotor end Pappenheimer

1945,

was

(39), in

that 1% oholine inhibits the deposition of oeroid pig-

ment in the cirrhotic livers of rats resulting from a low protein
diet containing excess amounts of cystine.

•ceriod• is a yellow

fluorescent, acid fast pigment often found in large am:,unts in
the livers of rats suffering from nutritional cirrhosis.

It

is not found in livers of human patients suffering from cirrhosis
of the liver so this finding is probably of little concern to us.
However, it is interesting to note that Victor and Pappenheimer
produced the cirrhosis by feeding diets low in protein and rich
in cystine •

It has been seen that cystine al one seemed only to

augment the condition of toxic hepatitis.
In Maroh of 1946, Morrison (40) reported a series of 20 cases
whioh he treated for two years with an intensive combined therapy
consisting of a maxil!Dlm protein, low fat, high carbohydrate diet
supplemented by daily injections of 5 cc•s. of whole liver extract
fortified with high potency vitamin B complex in large dosage, oral
vitamin B complex and multi-vitamin capsules, and by two grams each
of methionine and choline daily.

Such a method of treatment re-

sulted in a sharp reduction in the mortality, morbidity, and
disability rates in the series of patients presented.

Here again

the excellent results reported cannot be attributed to the methionine or choline alone.
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The first and up to the present date, the only decisive and
specific work on the treatment of cirrhosis of the liver with the
sulphur, containing amino acids, was done by A. J. Beams
Cleveland, Ohio, in

(41) of

1946. He treated 20 patients with port al cir-

rhosis with high protein, high carbohydrate, and fat diets, plus

1.5 - 3 grams of choline and the same amount of cystine daily for
1-5 months. 12 of these patients had enlarged livers and 8 had
livers which were not palpably enlarged.

15 patients with en•

larged livers and ascites received the same diet, but no choline
or cystine.

This latter group was used as a control group for

comparison.

All of the patients had advanced liver failure, evi-

denced by clinical signs and low serum albumen.

The 12 patients

whose livers were not enlarged, showed no response to therapy,
whereas 7 of the 8 patients with large livers made a good recovery
from liver decompensation.

A comparison of the treated group of

patients with large livers and the control group indicated that
the combination of choline and cystine had a favorable influence
on the cirrhotic condition.

The striking difference in the re-

sponse of those with large and non-enlarged livers, suggests
the fact that choline plus eystine is effective only upon the
enlarged livers where the connective tissue has not secondarily
contracted down and that when this process has taken place, resulting in the shrunken hobnail type of liver, the process is
irreversible.
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Dr.

Eddy

(42) in his abstraotion of Dr. Beam's article,

states that he used methionine alone instead of cystine plus
choline and received similar results.

He agreed that . the patients

should be treated early, before the contraction of the liver takes
place.

All of his advanced cases of portal cirrhosis died in spite

of treatment, but both of his two early vases made uneventful recoveries on the methionine therapy.

Dr. Beams, himself, in a later writing, (43), agreed with
Dr. Eddy that cystine plus choline have no advantage over methionine alone and stated that he had used methionine himself with
similar results.
Dr. Nolan Kaltreider {44), 1946, treated a small series of
oases of portal cirrhosis with choline oystine mixtures and methio-

nine.

He reported definite clinical improvement but stated that they

might have recovered even though this type of treatment had not been
instituted.
Charles Hoagland

(45) and Paul Gyorgy (46) in abstractions of

the article by Dr. Beams (41) spoke encouragingly concerning this
type of treatment.

They both agreed that the matter shoµld be

investigated more thoroughly and that the patients should be followed for a longer period of time before any definite conclusions
could be drawn.
The failure of the treatment in patients with the contracted
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livers seemed to support the generally accepted belief that fibrosis of the cirrhotic liver is an irreversible change and that
no structural repair is possible after the soar tissue has been
laid down and the hepatic parenchyma subdivided haphazardly.
ever, Steinberg and Martin

How-

(47), in 1946, presented evidence which

casts a shadow of doubt upon the above contention.

They produced

nodular cirrhosis of the liver in rats by feeding a diet of butter
yellow, rice. and carrots.

A colloidal suspension of thorium

dioxide injected intracardially, visualized the liver of the normal
animal as a diffuse roentgenographic shadow.
this shadow was altered.
appearance.

As cirrhosis developed

Ring shadows replaced the normal diffuse

These ring shadows indicated the degree and extent

of the cirrhosis.

On return of the animals to a normal stock diet,

some of them showed _p rogressive improvement, with partial or complete disappearance of connective tissue and nodular cirrhos'ia.
The improvement was characterized by gradual rep~acement of the
ring shadows by diffuse shadows.

The gross and histological

changes were found to correspond with the roentgenographic alterations.
This experiment, of course, does not prove conclusively
that fibrosis of the liver is a reversible process but it does
leave the door open for subsequent investigation along this liA••
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VII
SUMMARY AND CONCLUSIONS

SUMMARY AND CONCLUS IONS
Methionine or cystine plus choline are of definite value
in treating patients suffering from toxic hepatitis caused by
chloroform, arsphenamine, tro nitro toluene, carbon tetrachloride,
mapharsen, and ethylene dichloride.

Cystine administered alone

actually increases the liver damage.
The sulphur containing amino acids are of little or no value
in treating cases of infectious hepatitis or malarial hepatitis.
Methionine and cystine plus choline are found to be lipotropic substances in respect to their action upon fatty livers.
The question of the relationship of the above substances to lipocaic is undecided •
./

Cirrhosis of the liver caused by chemical intoxicant can be
treated effioacioµsly by the use of methionine or cystine plus
choline.

This type of therapy seems to be of some value also in
,

treating cases of portal cirrhosis of any other etiology.

However,

the number of cases of portal cirrhosis so treated is very limited
and considerable investigati~e work is yet to be do~e before any
definite conclusions can be drawn.
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